These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6913211)

  • 1. [Drug information: antiparkinson agents].
    Veje JO
    Sygeplejersken; 1981 Aug; 81(32):10. PubMed ID: 6913211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of Parkinson disease].
    Schneider E
    Med Monatsschr Pharm; 2000 Apr; 23(4):116-24. PubMed ID: 10812899
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effectiveness of the use of new types of antiparkinson agents].
    Federmann J; Honzáková L; Roth B; Stika L
    Cesk Zdrav; 1981 Jun; 29(6):229-41. PubMed ID: 7261170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parkinson therapy. New agents in the medical treatment of Parkinson disease].
    Ulm G
    Med Monatsschr Pharm; 1987 Oct; 10(10):304-7. PubMed ID: 3316955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changing drug therapy of Parkinson disease].
    Rinne UK
    Duodecim; 1993; 109(20):1763-8. PubMed ID: 7736999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmaceutical care of Parkinson patients].
    Lennecke K
    Med Monatsschr Pharm; 2005 Jul; 28(7):228-36; quiz 237-8. PubMed ID: 16038120
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of Parkinson (author's transl)].
    Kaeser HE
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2247-9. PubMed ID: 7312828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 9. Old versus new antiparkinsonian agents?
    Reynolds NC
    Wis Med J; 1985 Oct; 84(10):20-2. PubMed ID: 4072238
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson disease.
    Friedman JH
    N Y State J Med; 1987 Mar; 87(3):139-40. PubMed ID: 3472108
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parkinson disease--planning of long-term therapy].
    Nervenarzt; 1997 Dec; 68(12 Suppl Morbus Par):1-8. PubMed ID: 9439751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of later phases of Parkinson disease].
    Tison F
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F85-8. PubMed ID: 18680823
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances in the research of anti-parkinson agents].
    Liu DK; Wu YL; Pan XP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):240-5. PubMed ID: 3908019
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of parkinsonism.
    Celesia GG
    Curr Psychiatr Ther; 1977; 17():219-25. PubMed ID: 598230
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glutamic acid antagonists as antiparkinson agents?].
    Schmidt WJ
    Dtsch Med Wochenschr; 1992 Apr; 117(17):682-3. PubMed ID: 1349276
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatments in the early stage of Parkinson disease].
    Rascol O
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F77-84. PubMed ID: 18680822
    [No Abstract]   [Full Text] [Related]  

  • 17. [Parkinsonism].
    Stoliarova LG; Kadykov AS
    Klin Med (Mosk); 1984 May; 62(5):115-20. PubMed ID: 6748569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic treatment in Parkinson disease].
    García de Yébenes J; Fontán A; Rojo A
    Neurologia; 1999 May; 14 Suppl 1():17-33. PubMed ID: 10377727
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of Parkinson disease].
    Jiménez-Jiménez FJ
    Med Clin (Barc); 1999 Feb; 112(7):257-8. PubMed ID: 10220753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy of Parkinson's disease].
    Myllylä V
    Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.